Analysts' outlook on Coherus BioSciences turns pessimistic with a significant cut to revenue estimates. Despite predicting faster revenue growth than the market, the drastic downgrade for next year's forecasts raises concerns about future performance.
🔔 Ding Ding, Rings the Market, Let’s Get Going! ✅1️⃣ RVSN Long > 2.39 Short < 2.10 ✅2️⃣ LIFW Long > 1.52 Short < 1.37 ✅3️⃣ NCL Long > 1.67 Short < 1.51 ✅4️⃣ CHRS Long > 2.91 Short < 2.72 ✅5️⃣ PHUN Long > 0.2825 Short < 0.2758 Gear up for another day of market wins!
$Coherus BioSciences(CHRS.US)$Coherus Biosciences Has Announced The Termination Of Its Tigit Program Collaboration With Shanghai Junshi Biosciences, With Plans To Wind Down Their Work In The Coming Months Benzinga· 3 mins ago
Coherus BioSciences股票讨论区
Actually pretty good news going forward for company’s financial health
Dow Jones· 5 mins ago
Disclaimer: just what I'm up to
✅1️⃣ RVSN Long > 2.39 Short < 2.10
✅2️⃣ LIFW Long > 1.52 Short < 1.37
✅3️⃣ NCL Long > 1.67 Short < 1.51
✅4️⃣ CHRS Long > 2.91 Short < 2.72
✅5️⃣ PHUN Long > 0.2825 Short < 0.2758
Gear up for another day of market wins!
Update
Update
Benzinga· 3 mins ago
暂无评论